| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.704 | Human |
| regulation of rna splicing | GO:0043484 | 37 | 0.522 | |
| spliceosomal complex assembly | GO:0000245 | 6 | 0.472 | |
| rna catabolic process | GO:0006401 | 29 | 0.438 | |
| negative regulation of dna templated transcription termination | GO:0060567 | 1 | 0.421 | |
| translation | GO:0006412 | 93 | 0.294 | |
| mrna catabolic process | GO:0006402 | 22 | 0.278 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.261 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.252 | |
| mrna metabolic process | GO:0016071 | 84 | 0.252 | Human |
| poly a mrna export from nucleus | GO:0016973 | 4 | 0.251 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.248 | |
| pore complex assembly | GO:0046931 | 3 | 0.246 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.245 | Human |
| negative regulation of rna splicing | GO:0033119 | 12 | 0.242 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.232 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.220 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.209 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.196 | |
| rna processing | GO:0006396 | 105 | 0.194 | Human |
| regulation of translation | GO:0006417 | 71 | 0.191 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.186 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.181 | |
| mrna processing | GO:0006397 | 63 | 0.176 | Human |
| nuclear export | GO:0051168 | 34 | 0.175 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.169 | |
| heterochromatin organization | GO:0070828 | 4 | 0.156 | |
| gonad development | GO:0008406 | 141 | 0.153 | |
| nuclear transcribed mrna catabolic process nonsense mediated decay | GO:0000184 | 1 | 0.143 | |
| protein complex disassembly | GO:0043241 | 40 | 0.138 | |
| nuclear transport | GO:0051169 | 139 | 0.131 | |
| germ cell development | GO:0007281 | 185 | 0.127 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.105 | |
| response to heat | GO:0009408 | 27 | 0.103 | |
| circadian rhythm | GO:0007623 | 114 | 0.101 | |
| dna repair | GO:0006281 | 107 | 0.100 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.099 | |
| dna metabolic process | GO:0006259 | 303 | 0.098 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.094 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.092 | |
| negative regulation of mrna splicing via spliceosome | GO:0048025 | 12 | 0.092 | |
| negative regulation of translation | GO:0017148 | 22 | 0.091 | |
| organelle fission | GO:0048285 | 170 | 0.086 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.086 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.084 | |
| negative regulation of apoptotic cell clearance | GO:2000426 | 1 | 0.082 | |
| negative regulation of purine nucleotide catabolic process | GO:0033122 | 9 | 0.081 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.080 | |
| rna splicing | GO:0008380 | 54 | 0.080 | Human |
| mitotic cell cycle process | GO:1903047 | 159 | 0.078 | |
| rna transport | GO:0050658 | 18 | 0.077 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.077 | |
| gene silencing by rna | GO:0031047 | 19 | 0.076 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.075 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.075 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.074 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.074 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.073 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.072 | Human |
| regulation of rna stability | GO:0043487 | 26 | 0.071 | |
| chromatin organization | GO:0006325 | 206 | 0.071 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.071 | |
| 3 utr mediated mrna stabilization | GO:0070935 | 2 | 0.070 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.069 | |
| dna templated transcription termination | GO:0006353 | 4 | 0.065 | |
| nuclear transcribed mrna catabolic process | GO:0000956 | 16 | 0.065 | |
| nuclear mrna surveillance | GO:0071028 | 1 | 0.062 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.062 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.061 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.061 | |
| camera type eye development | GO:0043010 | 266 | 0.060 | |
| striated muscle contraction | GO:0006941 | 45 | 0.060 | |
| regulation of dna templated transcription termination | GO:0031554 | 1 | 0.059 | |
| maintenance of location | GO:0051235 | 89 | 0.059 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.058 | |
| negative regulation of protein complex disassembly | GO:0043242 | 22 | 0.057 | |
| oocyte construction | GO:0007308 | 2 | 0.056 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.056 | |
| nucleic acid transport | GO:0050657 | 18 | 0.055 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.054 | |
| establishment of rna localization | GO:0051236 | 18 | 0.054 | |
| stem cell development | GO:0048864 | 219 | 0.053 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.051 | |
| spermatid differentiation | GO:0048515 | 115 | 0.051 | |
| chromatin modification | GO:0016568 | 187 | 0.051 | |
| negative regulation of mrna processing | GO:0050686 | 12 | 0.051 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.051 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.049 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.049 | |
| amine metabolic process | GO:0009308 | 45 | 0.049 | |
| gene silencing | GO:0016458 | 38 | 0.048 | |
| regionalization | GO:0003002 | 337 | 0.048 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.048 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.048 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.047 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.047 | |
| myosin filament organization | GO:0031033 | 3 | 0.047 | |
| muscle contraction | GO:0006936 | 101 | 0.047 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.046 | |
| negative regulation of mrna metabolic process | GO:1903312 | 13 | 0.045 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.045 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.044 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.044 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.044 | |
| stem cell maintenance | GO:0019827 | 130 | 0.044 | |
| regulation of protein localization | GO:0032880 | 231 | 0.044 | |
| protein import into nucleus | GO:0006606 | 95 | 0.043 | |
| positive regulation of nfat protein import into nucleus | GO:0051533 | 1 | 0.042 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.042 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.042 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.042 | |
| multicellular organism growth | GO:0035264 | 161 | 0.042 | |
| germ cell proliferation | GO:0036093 | 7 | 0.041 | |
| termination of rna polymerase ii transcription | GO:0006369 | 1 | 0.041 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.041 | |
| mrna export from nucleus | GO:0006406 | 11 | 0.041 | |
| rna interference | GO:0016246 | 2 | 0.041 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.041 | |
| ossification | GO:0001503 | 216 | 0.040 | |
| rna localization | GO:0006403 | 23 | 0.040 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.039 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.038 | |
| regulation of protein transport | GO:0051223 | 163 | 0.038 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.037 | |
| body morphogenesis | GO:0010171 | 45 | 0.037 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.037 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.037 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.037 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.037 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.036 | |
| mrna splice site selection | GO:0006376 | 5 | 0.036 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.036 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.036 | |
| nuclear division | GO:0000280 | 158 | 0.035 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.035 | |
| positive regulation of rna splicing | GO:0033120 | 12 | 0.035 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.035 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.034 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.034 | |
| mrna transport | GO:0051028 | 13 | 0.033 | |
| transcription coupled nucleotide excision repair | GO:0006283 | 2 | 0.033 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.033 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.032 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.032 | |
| cell junction organization | GO:0034330 | 77 | 0.032 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.031 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.030 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.030 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.030 | |
| rna stabilization | GO:0043489 | 9 | 0.030 | |
| oxidation reduction process | GO:0055114 | 342 | 0.030 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.030 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.029 | |
| axonogenesis | GO:0007409 | 274 | 0.029 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.029 | |
| oocyte axis specification | GO:0007309 | 2 | 0.029 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.028 | |
| skin development | GO:0043588 | 220 | 0.028 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.028 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.028 | |
| visual perception | GO:0007601 | 52 | 0.028 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.027 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.027 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.027 | |
| muscle system process | GO:0003012 | 141 | 0.027 | |
| intracellular protein transport | GO:0006886 | 204 | 0.027 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.026 | |
| endocytosis | GO:0006897 | 168 | 0.026 | |
| protein localization to organelle | GO:0033365 | 185 | 0.026 | |
| dna conformation change | GO:0071103 | 37 | 0.026 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.026 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.026 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.025 | |
| methylation | GO:0032259 | 134 | 0.025 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.025 | |
| nucleus organization | GO:0006997 | 45 | 0.024 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.024 | |
| stem cell differentiation | GO:0048863 | 268 | 0.024 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.024 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.024 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.024 | |
| ear development | GO:0043583 | 200 | 0.024 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.023 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.023 | |
| spermatid nucleus differentiation | GO:0007289 | 19 | 0.023 | |
| circulatory system process | GO:0003013 | 197 | 0.023 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.023 | |
| protein targeting to membrane | GO:0006612 | 20 | 0.023 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.023 | |
| protein targeting | GO:0006605 | 143 | 0.023 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.023 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.022 | |
| protein import | GO:0017038 | 101 | 0.022 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.022 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.022 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.022 | |
| adult behavior | GO:0030534 | 135 | 0.021 | |
| microtubule based process | GO:0007017 | 236 | 0.021 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.021 | |
| positive regulation of protein export from nucleus | GO:0046827 | 4 | 0.021 | |
| phagocytosis | GO:0006909 | 66 | 0.021 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.021 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.021 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.021 | |
| embryonic axis specification | GO:0000578 | 30 | 0.021 | |
| positive regulation of glycogen catabolic process | GO:0045819 | 2 | 0.020 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.020 | |
| angiogenesis | GO:0001525 | 201 | 0.020 | |
| rhythmic process | GO:0048511 | 174 | 0.020 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.020 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.020 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.019 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.019 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.019 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.019 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.019 | |
| positive regulation of translation | GO:0045727 | 19 | 0.019 | |
| nuclear import | GO:0051170 | 95 | 0.019 | |
| membrane organization | GO:0061024 | 245 | 0.019 | |
| blood circulation | GO:0008015 | 195 | 0.019 | |
| positive regulation of protein localization to nucleus | GO:1900182 | 30 | 0.018 | |
| spermatogenesis | GO:0007283 | 284 | 0.018 | |
| viral process | GO:0016032 | 41 | 0.018 | |
| oogenesis | GO:0048477 | 56 | 0.018 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.018 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.018 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.018 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.018 | |
| locomotory behavior | GO:0007626 | 195 | 0.018 | |
| sensory perception | GO:0007600 | 245 | 0.018 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.018 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.018 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.017 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.017 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.017 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.017 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 4 | 0.017 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.017 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.017 | |
| respiratory system development | GO:0060541 | 190 | 0.017 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.017 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.017 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.016 | |
| single organism nuclear import | GO:1902593 | 95 | 0.016 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.016 | |
| response to starvation | GO:0042594 | 65 | 0.016 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.016 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.016 | |
| cell maturation | GO:0048469 | 127 | 0.016 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.016 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.016 | |
| protein localization to chromosome centromeric region | GO:0071459 | 1 | 0.016 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.016 | |
| response to nutrient levels | GO:0031667 | 109 | 0.016 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.016 | |
| neuron projection extension | GO:1990138 | 64 | 0.016 | |
| negative regulation of cardiac muscle cell proliferation | GO:0060044 | 5 | 0.016 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.016 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.016 | |
| fertilization | GO:0009566 | 127 | 0.015 | |
| histone deacetylation | GO:0016575 | 26 | 0.015 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.015 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.015 | |
| positive regulation of cytoplasmic transport | GO:1903651 | 40 | 0.015 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.015 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.015 | |
| neuron migration | GO:0001764 | 122 | 0.015 | |
| chemotaxis | GO:0006935 | 247 | 0.014 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.014 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.014 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.014 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.014 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.014 | |
| spermatid development | GO:0007286 | 108 | 0.014 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.014 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.014 | |
| developmental cell growth | GO:0048588 | 84 | 0.013 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.013 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.013 | |
| organelle assembly | GO:0070925 | 177 | 0.013 | |
| regulation of binding | GO:0051098 | 111 | 0.013 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.013 | |
| negative regulation of neuron projection regeneration | GO:0070571 | 3 | 0.013 | |
| fungiform papilla development | GO:0061196 | 6 | 0.013 | |
| negative regulation of b cell differentiation | GO:0045578 | 4 | 0.013 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.013 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.013 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.013 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.013 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.013 | |
| viral gene expression | GO:0019080 | 3 | 0.013 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.013 | |
| cell junction assembly | GO:0034329 | 52 | 0.013 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.013 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.013 | |
| maintenance of protein localization in organelle | GO:0072595 | 2 | 0.013 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.013 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.013 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.012 | |
| positive regulation of mrna metabolic process | GO:1903313 | 17 | 0.012 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.012 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.012 | |
| negative regulation of nucleotide catabolic process | GO:0030812 | 9 | 0.012 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.012 | |
| ribonucleoprotein complex disassembly | GO:0032988 | 3 | 0.012 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.012 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.012 | |
| cell substrate junction assembly | GO:0007044 | 24 | 0.012 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.012 | |
| determination of adult lifespan | GO:0008340 | 11 | 0.012 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.012 | |
| forebrain development | GO:0030900 | 302 | 0.012 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.012 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.012 | |
| male gamete generation | GO:0048232 | 285 | 0.012 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.012 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.012 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.011 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.011 | |
| heart process | GO:0003015 | 94 | 0.011 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.011 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.011 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.011 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.011 | |
| genitalia development | GO:0048806 | 37 | 0.011 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.011 | Human |
| response to temperature stimulus | GO:0009266 | 55 | 0.011 | |
| primary mirna processing | GO:0031053 | 1 | 0.011 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.011 | |
| neuron death | GO:0070997 | 154 | 0.011 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.011 | |
| mrna stabilization | GO:0048255 | 9 | 0.011 | |
| segmentation | GO:0035282 | 93 | 0.011 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.010 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 8 | 0.010 | |
| positive regulation of binding | GO:0051099 | 49 | 0.010 | |
| genetic imprinting | GO:0071514 | 27 | 0.010 | |
| response to insulin | GO:0032868 | 100 | 0.010 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.010 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.010 | |
| snorna metabolic process | GO:0016074 | 1 | 0.010 | |
| negative regulation of atpase activity | GO:0032780 | 2 | 0.010 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.010 | |
| respiratory tube development | GO:0030323 | 167 | 0.010 | |
| nucleobase containing compound transport | GO:0015931 | 27 | 0.010 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.010 | |
